Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 7/20 | 0.36 |
| ▸ | JAK2 | O60674 | 3/20 | 0.36 |
| ▸ | ITK | Q08881 | 2/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.33 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.33 |
| ▸ | SGK1 | O00141 | 1/20 | 0.33 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9909085 | 0.84 | ADORA2A (0.46) | ADORA2AADORA2BCYP1A2PDPK1JAK2 | |
| SCHEMBL31552439 | 0.79 | ITK (0.53) | ADORA2AADORA2BCYP1A2ITKMAP2K4 | |
| SCHEMBL12247 | 0.79 | ITK (0.53) | ADORA2AADORA2BCYP1A2ITKMAP2K4 | |
| SCHEMBL12292289 | 0.78 | PDPK1 (0.60) | PDPK1JAK2AURKATGFBR1ROCK1 | |
| SCHEMBL8212257 | 0.76 | MAP2K4 (0.56) | ADORA2AADORA2BITKMAP2K4CDK1 | |
| SCHEMBL11034 | 0.76 | PDPK1 (0.63) | ADORA2AADORA2BCYP1A2PDPK1JAK2 | |
| SCHEMBL588513 | 0.76 | AXL (0.50) | ADORA2AADORA2BCYP1A2PDPK1JAK2 | |
| SCHEMBL21937470 | 0.76 | ADORA2A (0.46) | ADORA2AADORA2BCYP1A2PDPK1JAK2 | |
| SCHEMBL176952 | 0.76 | PDPK1 (0.59) | ADORA2AADORA2BCYP1A2PDPK1JAK2 | |
| SCHEMBL3155790 | 0.76 | CHEK1 (0.50) | ADORA2AADORA2BCYP1A2MAP2K4DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120010181-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | MERCK SHARP & DOHME CORP. | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010181-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | TNF, ADAMTS1, ADAMTS7 | ADORA2A 3925/4885ADORA2B 2755/4885CYP1A2 1067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.